increased anxiety on glp 1 Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Starting GLP-1s: What Users Wish

I used their prenatals during two of my past pregnancies

Pharmacologic approaches to glycemic treatment: standards of medical Care in Diabetes2020

Both medications are approved for blood sugar control in type 2 diabetes and offer cardiovascular risk reduction but Jardiance has the edge for patients with heart failure while Ozempic is better choice for those prioritizing significant weight loss

And only minor side effects

Diabetes 47: 6672, 1998

CANVAS demonstrated a 14% reduction in MACE in patients with T2DM and a high cardiovascular risk ( 4.1.2 Cardiovascular results in studies aimed at CVD The CREDENCE clinical trial evaluated the effects of canagliflozin (100 mg daily) versus placebo in 4,401 patients with T2DM and CKD